Live from the NIH registry
Studies recruiting near Deltona right now
Top 25 of 942 recruiting studies, sorted by proximity — each links to its official registry page
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Arnold Palmer Hospital for Children — Orlando, Florida (27.2 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
Migraine
Phase 2
Interventional 488 participants sought
Florida Neurology - Lake Mary — Lake Mary, Florida (11.9 mi)
· Sponsor: AbbVie
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
AdventHealth — Altamonte Springs, Florida (19.2 mi)
· Sponsor: Relay Therapeutics, Inc.
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
Narcolepsy Type 1
Phase 3
Interventional 150 participants sought
Alkermes Investigational Site — Winter Park, Florida (22.4 mi)
· Sponsor: Alkermes, Inc.
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Chronic Migraine
Phase 3
Interventional 420 participants sought
Pediatric Neurology & Epilepsy Center Of Central Florida - Winter Park /ID# 275263 — Winter Park, Florida (22.4 mi)
· Sponsor: AbbVie
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Orlando, Florida (27.2 mi)
· Sponsor: AstraZeneca
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms
Phase 3
Interventional 450 participants sought
AdventHealth Orlando — Orlando, Florida (27.2 mi)
· Sponsor: Eli Lilly and Company
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
Halifax Health Cancer Center for Hope - Daytona Beach — Daytona Beach, Florida (24.1 mi)
· Sponsor: NRG Oncology
Improving Mechanics and Confidence in the Hip Hinge
Hip Hinge, Hip and Knee Movement
N/A
Interventional 30 participants sought
University of Central Florida — Orlando, Florida (27.2 mi)
· Sponsor: University of Central Florida
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
MTAP-deleted Solid Tumors
Phase 1, Phase 2
Interventional 450 participants sought
Sarah Cannon Research Institute at Florida Cancer Specialists- Lake Nona — Orlando, Florida (27.2 mi)
· Sponsor: Bayer
Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS
COPD, Smoking
N/A
Interventional 290 participants sought
Omega Research Debary, LLC — DeBary, Florida (5.9 mi)
· Sponsor: Philip Morris Products S.A.
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Neuroblastoma
Phase 2
Interventional 93 participants sought
Arnold Palmer Hospital for Children — Orlando, Florida (27.2 mi)
· Sponsor: Giselle Sholler
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Ulcerative Colitis
Phase 4
Interventional 65 participants sought
Endoscopic Research Inc — Orlando, Florida (27.2 mi)
· Sponsor: Takeda
A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
Alzheimer Disease
Phase 4
Interventional 150 participants sought
Progressive Medical Research — Port Orange, Florida (20.8 mi)
· Sponsor: Alpha Cognition, Inc
Feasibility and Efficacy Study of the CardioPulmonary Management (CPM) System in Patients With Chronic Heart Failure
Heart Failure
N/A
Interventional 1,200 participants sought
Orlando Health — Orlando, Florida (27.2 mi)
· Sponsor: Analog Device, Inc.
Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy
IgA Nephropathy
Phase 4
Interventional 60 participants sought
Central Florida Kidney Specialists — Orlando, Florida (27.2 mi)
· Sponsor: Calliditas Therapeutics AB
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
Arrow Clinical Trails — Daytona Beach, Florida (24.1 mi)
· Sponsor: Duke University
Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis
Lewy Body Dementia Psychosis
Phase 2
Interventional 180 participants sought
Neurology Associates, P. A. — Maitland, Florida (21.2 mi)
· Sponsor: ACADIA Pharmaceuticals Inc.
A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Phase 3
Interventional 59 participants sought
Neurology Associates — Maitland, Florida (21.2 mi)
· Sponsor: Takeda
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Solid Tumor Cancer, Locally Advanced
Phase 1, Phase 2
Interventional 480 participants sought
Avenzo Therapeutics Recruiting Site — Orlando, Florida (27.2 mi)
· Sponsor: Avenzo Therapeutics, Inc.
Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa
Hidradenitis Suppurativa
Phase 1
Interventional 24 participants sought
International Clinical Research Tennessee Llc — Sanford, Florida (8.1 mi)
· Sponsor: Incyte Corporation
A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System
Atrial Fibrillation
N/A
Interventional 276 participants sought
Orlando Health Heart and Vascular Institute — Orlando, Florida (27.2 mi)
· Sponsor: Biosense Webster, Inc.
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Triple-Negative Breast Cancer
Phase 3
Interventional 1,530 participants sought
AdventHealth Altamonte Springs ( Site 0125) — Altamonte Springs, Florida (19.2 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
Cystic Fibrosis
N/A
Observational 400 participants sought
Central Florida Pulmonary Group — Orlando, Florida (27.2 mi)
· Sponsor: Nicole Hamblett
Pharmacokinetic Study of Vorasidenib in Severe Hepatically Impaired and Matched-Control Participants
Severe Hepatic Impairment, Normal Hepatic Function
Phase 1
Interventional 20 participants sought
Orlando Clinical Research Center — Orlando, Florida (27.2 mi)
· Sponsor: Institut de Recherches Internationales Servier (I.R.I.S.)